HSD 17B inhibitors represent a specialized class of small molecules designed to block the 17β-hydroxysteroid dehydrogenase enzyme, which plays a critical role in androgen metabolism by converting testosterone… Read more







HSD 17B inhibitors represent a specialized class of small molecules designed to block the 17β-hydroxysteroid dehydrogenase enzyme, which plays a critical role in androgen metabolism by converting testosterone into dihydrotestosterone. Research into these compounds focuses on their potential to manage androgen-dependent conditions, such as benign prostatic hyperplasia and prostate cancer, by modulating hormonal pathways. For laboratories investigating these therapeutic agents, this category provides essential tools for rigorous analytical testing, including impurity profiling and quantitative quality control. The collection comprises high-quality reference standards, metabolic degradation products, and stable isotope labelled compounds, which are indispensable for validating analytical methods, tracking metabolic pathways, and ensuring precise characterization during pharmaceutical development and stability studies. These materials allow researchers to accurately quantify levels and confirm the structural integrity of HSD 17B inhibitor candidates throughout the R&D process.